RONALD HUNT - 22 Jun 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director, 10%+ Owner
Signature
/s/ Ronald Hunt by Georgia Erbez, Attorney-in-Fact
Issuer symbol
HARP
Transactions as of
22 Jun 2022
Transactions value $
$44,999
Form type
4
Filing time
24 Jun 2022, 18:46:46 UTC
Previous filing
17 Jun 2022
Next filing
24 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +10,167 $0 10,167 22 Jun 2022 Common Stock 10,167 $2.01 Direct F1
transaction HARP Director Stock Option (Right to Buy) Award $44,998 +32,142 $1.4 32,142 22 Jun 2022 Common Stock 32,142 $2.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.
F2 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $45,000 ("Election Option").
F3 One-half of the Election Option vested and became exercisable on June 22, 2022, and 25% of each Election Option will vest and become exercisable on each of September 30, 2022 and December 31, 2022, subject to the continuous service of the Reporting Person with the Issuer through each vesting date.